Clinical trial

QLF4113 in Participants With Metastatic Prostate Cancer

NCT07636707

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-07-20

PhasePHASE1

Study timeline

Study start (estimated)2026-07-20Date precision: day

Registry last updated2026-06-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

QLF4113 for injectionDRUG

Sponsors & collaborators

Qilu Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07636707 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.